Altered phosphorylation of cytoskeleton proteins in sickle red blood cells: The role of protein kinase C, Rac GTPases, and reactive oxygen species

Blood Cells, Molecules, and Diseases

Volumn 45, Issue 1, 2010, Pages 41-45

  George, Alex ^a   Pushkaran, Suvarnamala ^a   Li, Lina ^a   An, Xiuli ^b   Zheng, Yi ^a   Mohandas, Narla ^b   Joiner, Clinton H ^a   Kalfa, Theodosia A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b NEW YORK BLOOD CENTER   (United States)

Author keywords

Cytoskeleton phosphorylation; Protein kinase C; Rac GTPases; Reactive oxygen species; Sickle cell disease

Indexed keywords

CYTOSKELETON PROTEIN; PROTEIN KINASE C; RAC PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; CELL DISRUPTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE STRUCTURE; FLOW CYTOMETRY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SICKLE CELL ANEMIA;

ANEMIA, SICKLE CELL; ANIMALS; CYTOSKELETAL PROTEINS; ERYTHROCYTES; HUMANS; PROTEIN KINASE C; RAC GTP-BINDING PROTEINS; REACTIVE OXYGEN SPECIES;

MUS;

EID: 77953139384     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2010.02.006     Document Type: Article

References (60)

1. Nagel R.L. Pleiotropic and epistatic effects in sickle cell anemia. Curr. Opin. Hematol. 2001, 8:105-110.
2. Platt O.S. Sickle cell anemia as an inflammatory disease. J. Clin. Invest. 2000, 106:337-338.
3. Heeney M.M., Ware R.E. Hydroxyurea for children with sickle cell disease. Pediatr. Clin. North Am. 2008, 55:483-501. x.
4. Ballas S.K., Mohandas N. Sickle red cell microrheology and sickle blood rheology. Microcirculation 2004, 11:209-225.
5. Kalfa T.A., Pushkaran S., Mohandas N., Hartwig J.H., Fowler V.M., Johnson J.F., Joiner C.H., Williams D.A., Zheng Y. Rac GTPases regulate the morphology and deformability of the erythrocyte cytoskeleton. Blood 2006, 108:3637-3645.
6. Ling E., Gardner K., Bennett V. Protein kinase C phosphorylates a recently identified membrane skeleton-associated calmodulin-binding protein in human erythrocytes. J. Biol. Chem. 1986, 261:13875-13878.
7. Waseem A., Palfrey H.C. Identification and protein kinase C-dependent phosphorylation of alpha-adducin in human fibroblasts. J. Cell Sci. 1990, 96(Pt 1):93-98.
8. Matsuoka Y., Li X., Bennett V. Adducin is an in vivo substrate for protein kinase C: phosphorylation in the MARCKS-related domain inhibits activity in promoting spectrin-actin complexes and occurs in many cells, including dendritic spines of neurons. J. Cell Biol. 1998, 142:485-497.
9. Barkalow K.L., Italiano J.E., Chou D.E., Matsuoka Y., Bennett V., Hartwig J.H. alpha-Adducin dissociates from F-actin and spectrin during platelet activation. J. Cell Biol. 2003, 161:557-570.
10. Larsson C. Protein kinase C and the regulation of the actin cytoskeleton. Cell. Signal. 2006, 18:276-284.
11. Hordijk P.L. Regulation of NADPH oxidases: the role of Rac proteins. Circ. Res. 2006, 98:453-462.
12. Mohandas N., Gallagher P.G. Red cell membrane: past, present, and future. Blood 2008, 112:3939-3948.
13. Matsuoka Y., Li X., Bennett V. Adducin: structure, function and regulation. Cell. Mol. Life Sci. 2000, 57:884-895.
14. Fowler V.M. Regulation of actin filament length in erythrocytes and striated muscle. Curr. Opin. Cell Biol. 1996, 8:86-96.
15. Perrotta S., Gallagher P.G., Mohandas N. Hereditary spherocytosis. Lancet 2008, 372:1411-1426.
16. Gallagher P.G. Update on the clinical spectrum and genetics of red blood cell membrane disorders. Curr. Hematol. Rep. 2004, 3:85-91.
17. Cohen C.M., Gascard P. Regulation and post-translational modification of erythrocyte membrane and membrane-skeletal proteins. Semin. Hematol. 1992, 29:244-292.
18. Ghatpande S.S., Goodman S.R. Ubiquitination of spectrin regulates the erythrocyte spectrin-protein-4.1-actin ternary complex dissociation: implications for the sickle cell membrane skeleton. Cell. Mol. Biol. (Noisy-le-grand) 2004, 50:67-74.
19. Pantaleo A., De Franceschi L., Ferru E., Vono R., Turrini F. Current knowledge about the functional roles of phosphorylative changes of membrane proteins in normal and diseased red cells. J. Proteomics 2010, 73:445-455.
20. Bragadin M., Ion-Popa F., Clari G., Bordin L. SHP-1 tyrosine phosphatase in human erythrocytes. Ann. N. Y. Acad. Sci. 2007, 1095:193-203.
21. Zhang S.H., Eckberg W.R., Yang Q., Samatar A.A., Tonks N.K. Biochemical characterization of a human band 4.1-related protein-tyrosine phosphatase, PTPH1. J. Biol. Chem. 1995, 270:20067-20072.
22. Bize I., Guvenc B., Robb A., Buchbinder G., Brugnara C. Serine/threonine protein phosphatases and regulation of K-Cl cotransport in human erythrocytes. Am. J. Physiol. 1999, 277:C926-C936.
23. Bordin L., Brunati A.M., Donella-Deana A., Baggio B., Toninello A., Clari G. Band 3 is an anchor protein and a target for SHP-2 tyrosine phosphatase in human erythrocytes. Blood 2002, 100:276-282.
24. Zipser Y., Piade A., Kosower N.S. Erythrocyte thiol status regulates band 3 phosphotyrosine level via oxidation/reduction of band 3-associated phosphotyrosine phosphatase. FEBS Lett. 1997, 406:126-130.
25. Manno S., Takakuwa Y., Mohandas N. Modulation of erythrocyte membrane mechanical function by protein 4.1 phosphorylation. J. Biol. Chem. 2005, 280:7581-7587.
26. Fields A.P., Gustafson W.C. Protein kinase C in disease: cancer. Methods Mol. Biol. 2003, 233:519-537.
27. Hofmann J. Protein kinase C isozymes as potential targets for anticancer therapy. Curr. Cancer Drug Targets 2004, 4:125-146.
28. Govekar R.B., Zingde S.M. Protein kinase C isoforms in human erythrocytes. Ann. Hematol. 2001, 80:531-534.
29. 2+ pump and K(Ca) channel in deoxygenated sickle cells. Am. J. Physiol. 1997, 273:C1206-C1214.
30. Laudanna C., Mochly-Rosen D., Liron T., Constantin G., Butcher E.C. Evidence of zeta protein kinase C involvement in polymorphonuclear neutrophil integrin-dependent adhesion and chemotaxis. J. Biol. Chem. 1998, 273:30306-30315.
31. Witters L.A., Vater C.A., Lienhard G.E. Phosphorylation of the glucose transporter in vitro and in vivo by protein kinase C. Nature 1985, 315:777-778.
32. 2+ pump activity by protein kinase C. J. Biol. Chem. 1988, 263:2195-2202.
33. + exchange in men. J. Hypertens 1998, 16:305-310.
34. + exchange. Am. J. Physiol. 1997, 272:C818-C826.
35. de Jong K., Rettig M.P., Low P.S., Kuypers F.A. Protein kinase C activation induces phosphatidylserine exposure on red blood cells. Biochemistry 2002, 41:12562-12567.
36. Jindal H.K., Ai Z., Gascard P., Horton C., Cohen C.M. Specific loss of protein kinase activities in senescent erythrocytes. Blood 1996, 88:1479-1487.
37. Ling E., Danilov Y.N., Cohen C.M. Modulation of red cell band 4.1 function by cAMP-dependent kinase and protein kinase C phosphorylation. J. Biol. Chem. 1988, 263:2209-2216.
38. Dzandu J.K., Johnson R.M. Membrane protein phosphorylation in intact normal and sickle cell erythrocytes. J. Biol. Chem. 1980, 255:6382-6386.
39. Fathallah H., Coezy E., de Neef R.S., Hardy-Dessources M.D., Giraud F. Inhibition of deoxygenation-induced membrane protein dephosphorylation and cell dehydration by phorbol esters and okadaic acid in sickle cells. Blood 1995, 86:1999-2007.
40. Johnson R.M., Dzandu J.K., Warth J.A. The phosphoproteins of the sickle erythrocyte membrane. Arch. Biochem. Biophys. 1986, 244:202-210.
41. 2+-dependent phosphorylation of human red cell membrane skeletal proteins. J. Biol. Chem. 1986, 261:7701-7709.
42. Apovo M., Gascard P., Rhoda M.D., Beuzard Y., Giraud F. Alteration in protein kinase C activity and subcellular distribution in sickle erythrocytes. Biochim. Biophys. Acta 1989, 984:26-32.
43. Chen J., Deng F., Li J., Wang Q.J. Selective binding of phorbol esters and diacylglycerol by individual C1 domains of the PKD family. Biochem. J. 2008, 411:333-342.
44. Hebbel R.P., Morgan W.T., Eaton J.W., Hedlund B.E. Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:237-241.
45. Hebbel R.P., Eaton J.W., Balasingam M., Steinberg M.H. Spontaneous oxygen radical generation by sickle erythrocytes. J. Clin. Invest. 1982, 70:1253-1259.
46. Kuypers F.A., Scott M.D., Schott M.A., Lubin B., Chiu D.T. Use of ektacytometry to determine red cell susceptibility to oxidative stress. J. Lab. Clin. Med. 1990, 116:535-545.
47. Hebbel R.P., Leung A., Mohandas N. Oxidation-induced changes in microrheologic properties of the red blood cell membrane. Blood 1990, 76:1015-1020.
48. Joiner C.H., Rettig R.K., Jiang M., Franco R.S. KCl cotransport mediates abnormal sulfhydryl-dependent volume regulation in sickle reticulocytes. Blood 2004, 104:2954-2960.
49. Gibson X.A., Shartava A., McIntyre J., Monteiro C.A., Zhang Y., Shah A., Campbell N.F., Goodman S.R. The efficacy of reducing agents or antioxidants in blocking the formation of dense cells and irreversibly sickled cells in vitro. Blood 1998, 91:4373-4378.
50. Wood K.C., Granger D.N. Sickle cell disease: role of reactive oxygen and nitrogen metabolites. Clin. Exp. Pharmacol. Physiol. 2007, 34:926-932.
51. Goh S.H., Josleyn M., Lee Y.T., Danner R.L., Gherman R.B., Cam M.C., Miller J.L. The human reticulocyte transcriptome. Physiol. Genomics 2007, 30:172-178.
52. Rhee S.G., Chang T.S., Bae Y.S., Lee S.R., Kang S.W. Cellular regulation by hydrogen peroxide. J. Am. Soc. Nephrol. 2003, 14:S211-S215.
53. Banerjee T., Kuypers F.A. Reactive oxygen species and phosphatidylserine externalization in murine sickle red cells. Br. J. Haematol. 2004, 124:391-402.
54. Wood K.C., Hebbel R.P., Granger D.N. Endothelial cell NADPH oxidase mediates the cerebral microvascular dysfunction in sickle cell transgenic mice. FASEB J. 2005, 19:989-991.
55. Mulloy J.C., Cancelas J.A., Filippi M.D., Kalfa T.A., Guo F., Zheng Y. Rho GTPases in hematopoiesis and hemopathies. Blood 2010, 115:936-947.
56. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 2007, 87:245-313.
57. Vecchione C., Aretini A., Marino G., Bettarini U., Poulet R., Maffei A., Sbroggio M., Pastore L., Gentile M.T., Notte A., Iorio L., Hirsch E., Tarone G., Lembo G. Selective Rac-1 inhibition protects from diabetes-induced vascular injury. Circ. Res. 2006, 98:218-225.
58. Price L.S., Langeslag M., ten Klooster J.P., Hordijk P.L., Jalink K., Collard J.G. Calcium signaling regulates translocation and activation of Rac. J. Biol. Chem. 2003, 278:39413-39421.
59. phox. FASEB J. 2009, 23:1011-1022.
60. phox and on NADPH oxidase activation. Biochemistry 2002, 41:7743-7750.